Global Aortic Interventional Devices Market Growth (Status and Outlook) 2023-2029

Global Aortic Interventional Devices Market Growth (Status and Outlook) 2023-2029

The aorta is the major arterial conduit conveying blood from the heart to the systemic circulation. It originates immediately beyond the aortic valve ascending initially. Then it curves, forming the aortic arch, and descends caudally adjacent to the spine. The ascending thoracic aorta gives off the coronary arteries.

The most commonly used interventions are balloon dilation (PTCA) and stenting.

LPI (LP Information)' newest research report, the “Aortic Interventional Devices Industry Forecast” looks at past sales and reviews total world Aortic Interventional Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Aortic Interventional Devices sales for 2023 through 2029. With Aortic Interventional Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aortic Interventional Devices industry.

This Insight Report provides a comprehensive analysis of the global Aortic Interventional Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aortic Interventional Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aortic Interventional Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aortic Interventional Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aortic Interventional Devices.

The global Aortic Interventional Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Aortic Interventional Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Aortic Interventional Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Aortic Interventional Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Aortic Interventional Devices players cover Medtronic, BD, Boston Scientific, Abbott Laboratories, Cordis, Acotec, Biotronik, Terumo Corporation and Shanghai MicroPort Endovascular MedTech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Aortic Interventional Devices market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Bracket System
Balloon Catheter System
Others

Segmentation by application
Aortic Dissection
Aortic Aneurysm
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
BD
Boston Scientific
Abbott Laboratories
Cordis
Acotec
Biotronik
Terumo Corporation
Shanghai MicroPort Endovascular MedTech
Cook Medical
Lepu Medical
Zylox-Tonbridge Medical
LeoMed
LifeTech Scientific Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.